Arginase: an emerging key player in the mammalian immune system
AUTOR(ES)
Munder, Markus
FONTE
Blackwell Publishing Ltd
RESUMO
The enzyme arginase metabolizes L-arginine to L-ornithine and urea. Besides its fundamental role in the hepatic urea cycle, arginase is also expressed the immune system of mice and man. While significant interspecies differences exist regarding expression, subcellular localization and regulation of immune cell arginase, associated pathways of immunopathology are comparable between species. Arginase is induced in murine myeloid cells mainly by Th2 cytokines and inflammatory agents and participates in a variety of inflammatory diseases by down-regulation of nitric oxide synthesis, induction of fibrosis and tissue regeneration. In humans, arginase I is constitutively expressed in polymorphonuclear neutrophils and is liberated during inflammation. Myeloid cell arginase-mediated L-arginine depletion profoundly suppresses T cell immune responses and this has emerged as a fundamental mechanism of inflammation-associated immunosuppression. Pharmacological interference with L-arginine metabolism is a novel promising strategy in the treatment of cancer, autoimmunity or unwanted immune deviation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2765586Documentos Relacionados
- Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives
- Arginase: marker, effector, or candidate gene for asthma?
- Gut: Key Element on Immune System Regulation
- Dodecin Is the Key Player in Flavin Homeostasis of ArchaeaS⃞
- MicroRNA in the immune system, microRNA as an immune system